GW&K Investment Management LLC increased its stake in shares of Steris Corp. (NYSE:STE) by 17.8% during the second quarter, Holdings Channel reports. The fund owned 210,026 shares of the company’s stock after buying an additional 31,763 shares during the period. GW&K Investment Management LLC’s holdings in Steris Corp. were worth $14,439,000 as of its most recent SEC filing.
A number of other institutional investors also recently bought and sold shares of STE. BKD Wealth Advisors LLC bought a new position in Steris Corp. during the second quarter valued at $208,000. Massmutual Trust Co. FSB ADV bought a new position in Steris Corp. during the first quarter valued at $250,000. Mount Lucas Management LP bought a new position in Steris Corp. during the first quarter valued at $313,000. Diversified Trust Co bought a new position in Steris Corp. during the second quarter valued at $320,000. Finally, Virginia Retirement System bought a new position in Steris Corp. during the first quarter valued at $341,000. 91.58% of the stock is owned by institutional investors.
Shares of Steris Corp. (NYSE:STE) traded up 0.05% during trading on Wednesday, hitting $73.16. 420,217 shares of the company’s stock were exchanged. Steris Corp. has a 12-month low of $61.38 and a 12-month high of $78.77. The company has a 50-day moving average of $71.26 and a 200-day moving average of $70.18. The company has a market cap of $6.30 billion, a P/E ratio of 42.02 and a beta of 1.16.
Steris Corp. (NYSE:STE) last released its earnings results on Tuesday, August 9th. The company reported $0.79 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.77 by $0.02. Steris Corp. had a net margin of 5.52% and a return on equity of 10.72%. The business earned $638.40 million during the quarter, compared to analyst estimates of $639.04 million. During the same quarter in the prior year, the firm earned $0.62 earnings per share. The company’s revenue for the quarter was up 45.1% compared to the same quarter last year. On average, equities analysts expect that Steris Corp. will post $3.90 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 27th. Stockholders of record on Tuesday, August 30th were issued a dividend of $0.28 per share. This is a positive change from Steris Corp.’s previous quarterly dividend of $0.25. The ex-dividend date was Friday, August 26th. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.53%. Steris Corp.’s dividend payout ratio is presently 68.71%.
Several equities analysts recently weighed in on STE shares. Northcoast Research raised shares of Steris Corp. from a “neutral” rating to a “buy” rating in a research note on Friday, June 3rd. Zacks Investment Research raised shares of Steris Corp. from a “sell” rating to a “hold” rating in a research note on Thursday, September 8th.
In other news, Director Richard Martin Steeves sold 204,778 shares of the company’s stock in a transaction on Wednesday, September 7th. The shares were sold at an average price of $71.19, for a total transaction of $14,578,145.82. Following the completion of the sale, the director now owns 165,434 shares of the company’s stock, valued at $11,777,246.46. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Walter M. Rosebrough, Jr. sold 15,000 shares of the company’s stock in a transaction on Wednesday, August 17th. The stock was sold at an average price of $71.08, for a total transaction of $1,066,200.00. The disclosure for this sale can be found here. Insiders own 2.52% of the company’s stock.
About Steris Corp.
STERIS Corporation (STERIS) is a provider of infection prevention and other procedural products and services. The Company is focused on healthcare, pharmaceutical and research. The Company operates through three business segments: Healthcare, Life Sciences and STERIS Isomedix Services. The Healthcare segment provides surgical, sterile processing, infection prevention and gastrointestinal solutions.
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris Corp. (NYSE:STE).
Receive News & Ratings for Steris Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris Corp. and related companies with MarketBeat.com's FREE daily email newsletter.